Panel: Getting Access Right – Building Evidence and Engagement Before Launch

Session details:

What happens before launch is often more important than what comes after. Successful teams are not only preparing the market with early access programs, disease state awareness, and payer engagement, but also shaping trial design and evidence plans with future reimbursement in mind. This session explores how organizations integrate payer insights, regulatory expectations, and real-world evidence into early strategies to de-risk launches and accelerate uptake.

• Learn how to design access and education programs that resonate with patients, providers, and payers
• Examine best practices for embedding payer and HTA insights into Phase 3 trial design to strengthen value and pricing discussions
• Understand how evolving policies and funding shifts are influencing evidence generation strategies
• Explore the role of real-world evidence in supplementing clinical trial data for payer negotiations and market access
• Recognize tactical steps to minimize launch risk and maximize ROI